ArticleAnnals of clinical and translational neurology2026
Disease Course After Anti-CD20 Discontinuation in Secondary Progressive Multiple Sclerosis-A Multicenter Long-Term Longitudinal Study.
Ferdinand Otto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.